Clinical trial
Magnetic Resonance Imaging (MRI) and Spectroscopy (MRS) Biomarkers of Neonatal Hypoxic Ischemic Encephalopathy
NCT01481207 is registered in ClinicalTrials.gov with University Children's Hospital, Zurich as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Magnetic Resonance Imaging (MRI) and Spectroscopy (MRS) Biomarkers of Neonatal Hypoxic Ischemic Encephalopathy
- Lead sponsor
- University Children's Hospital, Zurich
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2011
- Completion date
- July 9, 2019
- Enrollment
- 59 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypoxic ischemic encephalopathy